Condition
Wait or Treat
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Radiotherapy
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Terminated1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Radiotherapy1
- Surgery1
- Temozolomide1
Active Sponsors
- Cooperative Trials Group for Neuro-Oncology (COGNO)1
- European Organisation for Research and Treatment of Cancer - EORTC1
Top Investigators
EORTC Study Coordinator
Related Conditions
- Phase Iii1
- Temozolomide1
- Lowgrade Glioma1